eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*cardioP↑, *neuroP↑, *Inflam↓, *antiOx↓, *GutMicro↑, *Half-Life↑, *LDL↓, *adiP↓, *HDL↑, *CRP↓, *IL1β↓, *Risk↓, *Risk↓, *cognitive↑, *memory↑, *other↑, *BOLD↑, *NO↓, *MDA↓, *GSH↑, *VitC↑, *SOD↑, *GPx↑, *eff↓, *eff↓, *eff↓, *eff↝, *Risk↓,
*TumCP↓, *ROS↑, *eff↓, *MDA↑, *GSH↓, *MMP↓, *ATP↓, *LC3II↑, *p62↑, *Bcl-2↓, *BAX↑, *Casp3↑,
*BioAv↝, *eff↓, *BioAv↝, *BioAv↝, *eff↑, *Half-Life∅, *eff↑, *eff↑, *Dose∅, *eff↑,
*antiOx↑, *glucose↑, *eNOS↑, *NRF2↑, *MMP9↓, *VCAM-1↓, *NF-kB↓, *cardioP↑, *cognitive↑, *eff↓, *BBB↑, *IronCh↑, *GSH↑, *PKCδ↑, *ERK↑, *p38↑, *MAPK↑, *PI3K↑, *Akt↑, *PTEN↓, *AMPK↑, *GLUT4↑, *GLUT1↑, *Inflam↓,
*BioAv↑, *toxicity↓, *Imm↑, *eff↑, *Risk↓, *Weight↓, *eff↝, *BP↓, *GutMicro↑, *eff↓,
*P-gp/ABCB1↓, *NF-kB↑, *eff↓, *Dose↝,
| - |
in-vitro, |
HCC, |
HepG2 |
|
|
|
- |
in-vitro, |
Nor, |
HL7702 |
|
|
|
TumCCA↑, SLC12A5↓, ATF6↑, CHOP/DDIT3↑, GRP78/BiP↑, Casp3↑, ER Stress↝, *toxicity↓, *eff↓,
*eff↓,
*eff↓, Dose↝, eff↑, HDAC↓, ac‑H3↓, ac‑H4↓, *HCAR2↑, *Inflam↓, *ROS↓, *NRF2↑, *GSH↑, *CLDN1↑, *ZO-1↑, IL1β↓, IL6↓, COX2/PTGS2↓, eff↝, eff↑, other↝,
*antiOx↑, *AntiDiabetic↑, *cognitive↑, *AntiAg↑, *AntiAg↑, *LDL↓, *HDL↑, *BP↓, *eff↓, *ROS↓,
*eff↓, *BioAv↓, *eff↑, *BioAv↓, OATPs↓, MRP↓,
*Ingr↝, *Risk↓, *eff↓,
*mtDam↓, *eff↓, *eff↑, *FIS1↓, *lipid-P↓, *ATP↑,
*SCD1↓, *Weight↓, *Insulin↓, *IGF-1↓, *adiP↑, *eff↓,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
Apoptosis↑, *toxicity↓, *eff↓,
*Dose↝, *Hcy/homoC↓, *cognitive↑, *eff↓,
| - |
vitro+vivo, |
Nor, |
HUVECs |
|
|
|
- |
vitro+vivo, |
Diabetic, |
NA |
|
|
|
*BloodF↑, *Ferroptosis↓, *eff↓, *mtDam↓, *xCT/SLC7A11↑, *GPx4↑, *Wound Healing↑, *CD31/PECAM-1↑, *mt-ROS↓,
| - |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
Casp3↑, Casp9↑, Casp8↑, DR5↑, survivin↓, Bcl-2↓, XIAP↓, cFLIP↓, BAX↑, Cyt‑c↑, ROS↑, GSH↓, *eff↓,
*eff↑, *CompStab↓, *NRF2↑, *Inflam↓, *eff↑, *antiOx↑, *neuroP↑, *COX2/PTGS2↓, *NF-kB↓, *eff↓, *BioAv↝, *CompStab↑,
*Dose↝, *toxicity↑, *Casp3↑, *Casp9↑, *ROS↑, *MMP↓, *ATP↓, *eff↓,
*Ca+2↓, *eff↓, *ROS↓,
*BMD↑, *VGCC↑, *Ca+2↑, *NO↑, *eff↓,
*eff↓, eff↝, *Hif1a↑, *VEGF↑, *TIMP1↑, *E2Fs↑, *MMP2↑, *MMP9↑, Apoptosis↑,
*MPT↑, *Cyt‑c↑, *ROS↑, *p‑GSK‐3β↑, *eff↓, *MMP∅, *BAX↓, *Bcl-2∅,
*mt-OCR↑, *mt-ROS↑, *ECAR↑, *Dose↝, *Ca+2↑, *ATP↑, *other↑, *eff↓, *eff↝,
*BMD↑, *eff↓, *ALP↑, *other↑,
*Dose↝, *BBB↑, *eff↓,
*BioAv↓, *BioAv↑, *other↝, *eff↓,
*Dose?, *toxicity↓, *eff↓, *IPSS↝, *other↝, *UFR?, *5-AR↓, *Inflam↓,
*MitoP↑, *NRF2↑, Synergy↑, *eff↓, *GutMicro↑,
*CardioT↓, *NRF2↑, *eff↓, *ROS↓,
*neuroP↑, *Inflam↓, *iNOS↓, *TNF-α↓, *IL1β↓, *IL6↓, *ARG1/2↑, *TGF-β↑, *IL10↑, *NF-kB↓, *eff↓,
| - |
in-vivo, |
Nor, |
NA |
|
|
|
- |
in-vitro, |
Nor, |
HK-2 |
|
|
|
*ER Stress↓, *SIRT1↑, *NRF2↑, *HO-1↑, *eff↓, *RenoP↑, *GRP78/BiP↓, *CHOP/DDIT3↓, *Casp12↓, *BAX↓, *cl‑Casp3↓,
*cardioP↑, *ROS↓, *Inflam↓, *Mst1↓, *NRF2↑, *eff↓, *antiOx↑, *SOD↑, *GSH↑, *TNF-α↓, BAX↓, Bcl-2↑,
*HO-1↑, *NRF2↑, *e-ERK↑, *e-Akt↑, *AMPKα↑, *ROS⇅, *eff↓, *tumCV∅,
*memory↑, *Aβ↓, *toxicity↓, *BBB↑, *p‑tau↓, *eff↓, *IL1α↓, *MCP1/CCL2↓, *MIP‑1α/CCL3↓, *TNF-α↓, *IL2↓, *SIRT1↓, *DNAdam↓, *Dose↝, *Strength↑, *motorD↑, *CTSZ↓,
*Risk↓, *neuroP↑, *other?, *Ach↑, *other↝, *eff↓, *other↝,
Showing Research Papers: 1 to 37 of 37
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 37
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 1, ROS↑, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 2, BAX↓, 1, BAX↑, 1, Bcl-2↓, 1, Bcl-2↑, 1, Casp3↑, 2, Casp8↑, 1, Casp9↑, 1, cFLIP↓, 1, Cyt‑c↑, 1, DR5↑, 1, survivin↓, 1, XIAP↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
ac‑H3↓, 1, ac‑H4↓, 1, HDAC↓, 1, other↝, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ATF6↑, 1, CHOP/DDIT3↑, 1, ER Stress↝, 1, GRP78/BiP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 1,
Barriers & Transport(tgid=15) ⓘ
OATPs↓, 1, SLC12A5↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, IL1β↓, 1, IL6↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose↝, 1, eff↑, 2, eff↝, 2, MRP↓, 1, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Total Targets: 35
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1, antiOx↑, 4, GPx↑, 1, GPx4↑, 1, GSH↓, 1, GSH↑, 4, HDL↑, 2, HO-1↑, 2, lipid-P↓, 1, MDA↓, 1, MDA↑, 1, NRF2↑, 8, ROS↓, 5, ROS↑, 3, ROS⇅, 1, mt-ROS↓, 1, mt-ROS↑, 1, SOD↑, 2, VitC↑, 1, xCT/SLC7A11↑, 1,
Metal & Cofactor Biology(tgid=2) ⓘ
IronCh↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
FIS1↓, 1, Insulin↓, 1, mtDam↓, 2, mt-OCR↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
adiP↓, 1, adiP↑, 1, AMPK↑, 1, ATP↓, 2, ATP↑, 2, ECAR↑, 1, glucose↑, 1, p‑GSK‐3β↑, 1, LDL↓, 2, SCD1↓, 1, SIRT1↓, 1, SIRT1↑, 1,
Cell Death(tgid=5) ⓘ
BAX↓, 2, BAX↑, 1, Bcl-2↓, 1, Bcl-2∅, 1, Casp12↓, 1, Casp3↑, 2, cl‑Casp3↓, 1, Casp9↑, 1, Cyt‑c↑, 1, Ferroptosis↓, 1, iNOS↓, 1, p38↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↑, 1, e-Akt↑, 1, AMPKα↑, 1, ERK↑, 1, e-ERK↑, 1, HCAR2↑, 1, MAPK↑, 1, Mst1↓, 1, PI3K↑, 1, PKCδ↑, 1, PTEN↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other?, 1, other↑, 3, other↝, 4, tumCV∅, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↓, 1, ER Stress↓, 1, GRP78/BiP↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
CTSZ↓, 1, LC3II↑, 1, MitoP↑, 1, p62↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
E2Fs↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
IGF-1↓, 1, TumCP↓, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 2, ARG1/2↑, 1, Ca+2↓, 1, Ca+2↑, 2, MMP2↑, 1, MMP9↓, 1, MMP9↑, 1, TGF-β↑, 1, TIMP1↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
CD31/PECAM-1↑, 1, eNOS↑, 1, Hif1a↑, 1, NO↓, 1, NO↑, 1, VCAM-1↓, 1, VEGF↑, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 3, CLDN1↑, 1, GLUT1↑, 1, GLUT4↑, 1, MMP↓, 2, MMP∅, 1, MPT↑, 1, VGCC↑, 1, ZO-1↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, HCAR2↑, 1, IL10↑, 1, IL1α↓, 1, IL1β↓, 2, IL2↓, 1, IL6↓, 1, Imm↑, 1, Inflam↓, 7, MCP1/CCL2↓, 1, MIP‑1α/CCL3↓, 1, NF-kB↓, 3, NF-kB↑, 1, TNF-α↓, 3,
Synaptic & Neurotransmission(tgid=18) ⓘ
5-AR↓, 1, Ach↑, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 1, p‑tau↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 3, BioAv↑, 2, BioAv↝, 4, CompStab↓, 1, CompStab↑, 1, Dose?, 1, Dose↝, 6, Dose∅, 1, eff↓, 39, eff↑, 9, eff↝, 3, Half-Life↑, 1, Half-Life∅, 1, P-gp/ABCB1↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALP↑, 1, BloodF↑, 1, BMD↑, 2, BP↓, 2, CRP↓, 1, Hcy/homoC↓, 1, IL6↓, 1, UFR?, 1,
Functional Outcomes(tgid=23) ⓘ
AntiDiabetic↑, 1, BOLD↑, 1, cardioP↑, 3, CardioT↓, 1, cognitive↑, 4, IPSS↝, 1, memory↑, 2, motorD↑, 1, neuroP↑, 4, RenoP↑, 1, Risk↓, 6, Strength↑, 1, toxicity↓, 5, toxicity↑, 1, Weight↓, 2, Wound Healing↑, 1,
Infection & Microbiome(tgid=24) ⓘ
GutMicro↑, 3,
Ingredients & Constituents(tgid=25) ⓘ
Ingr↝, 1,
Total Targets: 158
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page